Guru Ownership Trend
Guru Analysis for Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 14 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $908.56 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $175.31 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Jeremy Grantham reduced exposure by 55.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Gilead Sciences, Inc. (GILD)
Major holders include Renaissance Technologies (RenTech) ($280.14 M), Steven Cohen ($181.64 M), Cliff Asness ($86.94 M). According to the latest reported data, 14 tracked investment managers collectively hold approximately 5.82 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $175.31 M, with 7 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 5 managers trimmed their positions, while 1 fully exited GILD. The total reported sell value was $63.54 M.
Yes, 0 managers opened new positions in GILD, and 7 increased their existing holdings. The total reported buy value was $238.85 M.
